Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study

Background Intravenous infusion of ketamine can produce rapid and large symptom reduction in patients with treatment-resistant depression (TRD) but presents major obstacles to clinical applicability, especially in community settings. Oral esketamine may be a promising addition to our TRD treatment...

Full description

Bibliographic Details
Main Authors: Sanne Y. Smith-Apeldoorn, Jolien K. E. Veraart, Henricus G. Ruhé, Marije aan het Rot, Jeanine Kamphuis, Marrit K. de Boer, Robert A. Schoevers
Format: Article
Language:English
Published: Cambridge University Press 2022-01-01
Series:BJPsych Open
Subjects:
Esketamine
oral administration
treatment-resistant depression
tolerability
safety
Online Access:https://www.cambridge.org/core/product/identifier/S2056472421010590/type/journal_article

Internet

https://www.cambridge.org/core/product/identifier/S2056472421010590/type/journal_article

Similar Items